Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis.
ERJ Open Res
; 6(4)2020 Oct.
Article
em En
| MEDLINE
| ID: mdl-33263051
ABSTRACT
Benralizumab reduces oral corticosteroid requirements in patients with EGPA and leads to improved patient-reported outcome measures https//bit.ly/2GI0vhf.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article